Protein | Peptide | MMS/CTL^{b} | CTL | MMS | Phosphorylation site |
---|---|---|---|---|---|
Rad53 | (K)IAS*PGLTSSTASSMVANK | 1.7 | X^{c} | X | 175 |
(K)DTSVS*PDEYEER | 2.7 | X | X | 375 | |
(K)KPPVSDTNNNGNNSVLNDLVES*PINANTGNILK | 2.8 | X | X | 774 | |
(K)MSPLGSQSYGDFSQISLSQSLS*QQK | 3.0 | X | X | 489 | |
(R)GKD(TS)*VSPDEYEER | 4.0 | X | (372–373) | ||
(R)DLS*ADISQVLK | 5.0 | X | 49 | ||
(R)IHS*VSLSQSQIDPSK | 6.8 | X | X | 789 | |
(K)FS*QEQIGENIVCR | 12.0 | X | X | 24 | |
(K)IPAHAPIRYT*QPK | 12.5 | X | 543 | ||
(R)IHS*VSLS*QSQIDPSK | 12.5 | X | 789/793 | ||
(K)VQGNGS*FMK | 14.3 | X | 350 | ||
(K)LLHS*NNTENVK | 14.3 | X | X | 560 | |
(K)QIGRGS*YHEGPLKDFR | 14.3 | X | 424 | ||
(K)S*IEAETR | 14.5 | X | 547 | ||
(R)ANQPSASS(SS)*MSAK | 59.0 | X | (747–748) | ||
Rad9 | (R)KSMTNVLS*PK | 3.5 | X | 937 | |
(K)EALHS*PLADGDMNEMNVPVDPLENK | 3.9 | X | 26 | ||
(R)INFEPILEVPETSS*PSK | 6.7 | X | 494 | ||
(R)NNQIIQ(SNES)*EEINELEK | 7.3 | X | (312–315) | ||
(K)RNS*DLDAASIKR | 7.9 | X | 729 | ||
(R)S*ADNYDCALEGIVTPK | 7.9 | X | 205 | ||
(K)NLMQLFPSES*QEIIQNR | 8.1 | X | 688 | ||
(K)SS*PDRVTQSAIK | 8.1 | X | 11 | ||
(K)VNSTNIIEGS*PK | 8.2 | X | 56 | ||
(R)LSLDS*PSK | 8.4 | X | 1136 | ||
(R)DALAEHAGAPSLLF(SS)*GEIR | 8.6 | X | (989–990) | ||
(K)NLNVS*GR | 16.0 | X | 328 | ||
Asf1 | (K)IEGGSTDIEST*PK | 3.3 | X | X | 270 |
Yta7 | (K)EQS*QENILQEPDLK | 7.5 | X | 1142 | |
(R)GGWNAS*QNSGPTR | 14.9 | X | 316 | ||
(K)ENEDS*LQTQVTEENFSK | 22.0 | X | 1256 | ||
Nup2 | (R)ETYD(SNES)*DDDVTPSTK | 7.2 | X | (17–20) |
↵ ^{a} Each asterisk indicates one phosphorylation event to the S/T residue to its left. In cases where the exact site is ambiguous due to clustering of multiple S/T residues, the possible candidate S/T residues are shown in parentheses.
↵ ^{b} Value for peptides identified only in MMS-treated samples should be considered as a signal-to-noise ratio.
↵ ^{c} X indicated the presence of the phosphopeptides in the indicated sample.